[Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient].
D000367:Age Factors; D000368:Aged; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006620:Hip Fractures / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D011446:Prospective Studies; D012189:Retrospective Studies; D000068296:Risedronic Acid; D012307:Risk Factors; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D002121:Calcium Channel Blockers; D000068296:Risedronic Acid; D012968:Etidronic Acid
Rascher und lang anhaltender Schutz mit Risedronat. Mit gestärkten Knochen länger autark.